ARTICLE | Company News
Icos, Raven antibody deal
June 9, 2004 7:00 AM UTC
Raven (South San Francisco, Calif.) granted an exclusive option to ICOS to license five preclinical monoclonal antibodies for therapeutic indications including cancer. Raven will receive an upfront pa...